Literature DB >> 11013034

Does the endovascular repair of aortoiliac aneurysms pose a radiation safety hazard to vascular surgeons?

E C Lipsitz1, F J Veith, T Ohki, S Heller, R A Wain, W D Suggs, J C Lee, S Kwei, K Goldstein, J Rabin, D Chang, M Mehta.   

Abstract

OBJECTIVES: Endovascular aortoiliac aneurysm (EAIA) repair uses substantial fluoroscopic guidance that requires considerable radiation exposure. Doses were determined for a team of three vascular surgeons performing 47 consecutive EAIA repairs over a 1-year period to determine whether this exposure constitutes a radiation hazard.
METHODS: Twenty-nine surgeon-made aortounifemoral devices and 18 bifurcated devices were used. Three surgeons wore dosimeters (1) on the waist, under a lead apron; (2) on the waist, outside a lead apron; (3) on the collar; and (4) on the left ring finger. Dosimeters were also placed around the operating table and room to evaluate the patient, other personnel, and ambient doses. Exposures were compared with standards of the International Commission on Radiological Protection (ICRP).
RESULTS: Total fluoroscopy time was 30.9 hours (1852 minutes; mean, 39.4 minutes per case). Yearly total effective body doses for all surgeons (under lead) were below the 20 mSv/y occupational exposure limit of the ICRP. Outside lead doses for two surgeons approximated recommended limits. Lead aprons attenuated 85% to 91% of the dose. Ring doses and calculated eye doses were within the ICRP exposure limits. Patient skin doses averaged 360 mSv per case (range, 120-860 mSv). The ambient (> 3 m from the source) operating room dose was 1.06 mSv/y.
CONCLUSIONS: Although the total effective body doses under lead fell within established ICRP occupational exposure limits, they are not negligible. Because radiation exposure is cumulative and endovascular procedures are becoming more common, individuals performing these procedures must carefully monitor their exposure. Our results indicate that a team of surgeons can perform 386 hours of fluoroscopy per year or 587 EAIA repairs per year and remain within occupational exposure limits. Individuals who perform these procedures should actively monitor their effective doses and educate personnel in methods for reducing exposure.

Entities:  

Mesh:

Year:  2000        PMID: 11013034     DOI: 10.1067/mva.2000.110053

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  6 in total

1.  The impact of radiological equipment on patient radiation exposure during endovascular aortic aneurysm repair.

Authors:  Rita Fossaceca; Marco Brambilla; Giuseppe Guzzardi; Paolo Cerini; Alessandra Renghi; Serena Valzano; Piero Brustia; Alessandro Carriero
Journal:  Eur Radiol       Date:  2012-05-23       Impact factor: 5.315

2.  Occupational radiation protection in interventional radiology: a joint guideline of the Cardiovascular and Interventional Radiology Society of Europe and the Society of Interventional Radiology.

Authors:  Donald L Miller; Eliseo Vañó; Gabriel Bartal; Stephen Balter; Robert Dixon; Renato Padovani; Beth Schueler; John F Cardella; Thierry de Baère
Journal:  Cardiovasc Intervent Radiol       Date:  2009-12-18       Impact factor: 2.740

3.  Radiation hazards to vascular surgeon and scrub nurse in mobile fluoroscopy equipped hybrid vascular room.

Authors:  Jong Bin Kim; Jaehoon Lee; Kihyuk Park
Journal:  Ann Surg Treat Res       Date:  2017-02-24       Impact factor: 1.859

4.  Pattern and degree of radiation exposure during endovascular surgery performed using a mobile C-arm or in a hybrid room.

Authors:  Cheng Quan; Sang Su Lee
Journal:  Ann Surg Treat Res       Date:  2018-02-26       Impact factor: 1.859

Review 5.  Artificial vascular models for endovascular training (3D printing).

Authors:  Inez Torres; Nelson De Luccia
Journal:  Innov Surg Sci       Date:  2018-08-11

6.  Analysis of radiation risk to patients from intra-operative use of the mobile X-ray system (C-arm).

Authors:  Yang-Sub Lee; Hae-Kag Lee; Jae-Hwan Cho; Ham-Gyum Kim
Journal:  J Res Med Sci       Date:  2015-01       Impact factor: 1.852

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.